PAPER Li F, Wang F, Jia J
SEARCH RESULTS
330026 RESULTS
PAPER Aguiar AS, Tristão FS, Amar M, Chevarin C, Glaser V, de Paula Martins R, Moreira EL, Mongeau R, Lanfumey L, Raisman-Vozari R, Latini A, Prediger RD
Six Weeks of Voluntary Exercise don't Protect C57BL/6 Mice Against Neurotoxicity of MPTP and MPP(+)
Neurotox Res. 2013 Jul 20; PubMed: 23873578PAPER Ahmed T, Gilani AH
Therapeutic Potential of Turmeric in Alzheimer's Disease: Curcumin or Curcuminoids?
Phytother Res. 2013 Jul 19; PubMed: 23873854PAPER Farfel JM, Nitrini R, Suemoto CK, Grinberg LT, Ferretti RE, Leite RE, Tampellini E, Lima L, Farias DS, Neves RC, Rodriguez RD, Menezes PR, Fregni F, Bennett DA, Pasqualucci CA, Jacob Filho W,
Very low levels of education and cognitive reserve: A clinicopathologic study.
Neurology. 2013 Aug 13;81(7):650-7. PubMed: 23873971PAPER Quental NB, Brucki SM, Bueno OF
Visuospatial function in early Alzheimer's disease--the use of the Visual Object and Space Perception (VOSP) battery.
PLoS One. 2013;8(7):e68398. PubMed: 23874610PAPER Maioli S, Båvner A, Ali Z, Heverin M, Ismail MA, Puerta E, Olin M, Saeed A, Shafaati M, Parini P, Cedazo-Minguez A, Björkhem I
Is it possible to improve memory function by upregulation of the cholesterol 24S-hydroxylase (CYP46A1) in the brain?
PLoS One. 2013;8(7):e68534. PubMed: 23874659PAPER Papadopoulos P, Rosa-Neto P, Rochford J, Hamel E
Pioglitazone improves reversal learning and exerts mixed cerebrovascular effects in a mouse model of Alzheimer's disease with combined amyloid-β and cerebrovascular pathology.
PLoS One. 2013;8(7):e68612. Print 2013 PubMed: 23874687PAPER Dowling NM, Gleason CE, Manson JE, Hodis HN, Miller VM, Brinton EA, Neal-Perry G, Santoro MN, Cedars M, Lobo R, Merriam GR, Wharton W, Naftolin F, Taylor H, Harman SM, Asthana S
Characterization of vascular disease risk in postmenopausal women and its association with cognitive performance.
PLoS One. 2013;8(7):e68741. PubMed: 23874743PAPER Hsiao FJ, Wang YJ, Yan SH, Chen WT, Lin YY
Altered oscillation and synchronization of default-mode network activity in mild Alzheimer's disease compared to mild cognitive impairment: an electrophysiological study.
PLoS One. 2013;8(7):e68792. PubMed: 23874766PAPER Johnson LA, Hall JR, O'Bryant SE
A depressive endophenotype of mild cognitive impairment and Alzheimer's disease.
PLoS One. 2013;8(7):e68848. PubMed: 23874786PAPER Maftei M, Thurm F, Schnack C, Tumani H, Otto M, Elbert T, Kolassa IT, Przybylski M, Manea M, von Arnim CA
Increased levels of antigen-bound β-amyloid autoantibodies in serum and cerebrospinal fluid of Alzheimer's disease patients.
PLoS One. 2013;8(7):e68996. PubMed: 23874844PAPER Sancheti H, Akopian G, Yin F, Brinton RD, Walsh JP, Cadenas E
Age-dependent modulation of synaptic plasticity and insulin mimetic effect of lipoic acid on a mouse model of Alzheimer's disease.
PLoS One. 2013;8(7):e69830. PubMed: 23875003PAPER Nasab NM, Bahrammi MA, Nikpour MR, Rahim F, Naghibis SN
Efficacy of rivastigmine in comparison to ginkgo for treating Alzheimer's dementia.
J Pak Med Assoc. 2012 Jul;62(7):677-80. PubMed: 23866514PAPER Bihaqi SW, Bahmani A, Subaiea GM, Zawia NH
Infantile exposure to lead and late-age cognitive decline: Relevance to AD.
Alzheimers Dement. 2013 Jul 15; PubMed: 23867794PAPER Karantzoulis S, Novitski J, Gold M, Randolph C
The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): Utility in Detection and Characterization of Mild Cognitive Impairment due to Alzheimer's Disease.
Arch Clin Neuropsychol. 2013 Jul 17; PubMed: 23867976Current Filters
No filters selected